Detection of synergistic combinatorial perturbations by a bifurcation-based approach. (English) Zbl 1472.92122
Summary: Drug combination has become an attractive strategy against complex diseases, despite the challenges in handling a large number of possible combinations among candidate drugs. How to detect effective drug combinations and determine the dosage of each drug in the combination is still a challenging task. When regarding a drug as a perturbation, we propose a bifurcation-based approach to detect synergistic combinatorial perturbations. In the approach, parameters of a dynamical system are divided into two groups according to their responses to perturbations. By combining two parameters chosen from two groups, three types of combinations can be obtained. Synergism for different perturbation combinations can be detected by relative positions of the bifurcation curve and the isobole. The bifurcation-based approach can be used not only to detect combinatorial perturbations but also to determine their perturbation quantities. To demonstrate the effectiveness of the approach, we apply it to the epithelial-to-mesenchymal transition (EMT) network. The approach has implications for the rational design of drug combinations and other combinatorial control, e.g. combinatorial regulation of gene expression.
MSC:
| 92C50 | Medical applications (general) |
| 37J40 | Perturbations of finite-dimensional Hamiltonian systems, normal forms, small divisors, KAM theory, Arnol’d diffusion |
| 37J20 | Bifurcation problems for finite-dimensional Hamiltonian and Lagrangian systems |
References:
| [1] | Angeli, D., Ferrell, J. E. & Sontag, E. D. [2004] “ Detection of multistability, bifurcations, and hysteresis in a large class of biological positive-feedback systems,” Proc. Natl. Acad. Sci. USA101, 1822-1827. |
| [2] | Argiris, A., Wang, C., Whalen, S. G. & DiGiovanna, M. P. [2004] “ Synergistic interactions between tamoxifen and trastuzumab (Herceptin),” Clin. Cancer Res.10, 1409-1420. |
| [3] | Balint, S., Kaslik, E., Balint, A. & Grigis, A. [2006] “ Methods for determination and approximation of the domain of attraction in the case of autonomous discrete dynamical systems,” Nonlin. Anal-Theor.60, 703-717. · Zbl 1134.39013 |
| [4] | Batlle, E., Sancho, E., Francĺ, C., Domĺnguez, D., Monfar, M., Baulida, J. & Herreros, A. G. [2000] “ The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells,” Nat. Cell Biol.2, 84-89. |
| [5] | Bendall, S. C., Davis, K. L., Amir, E. A. D.et al. [2014] “ Single-cell trajectory detection uncovers progression and regulatory coordination in human b cell development,” Cell157, 714-725. |
| [6] | Bliss, C. I. [1956] “ The calculation of microbial assays,” Bacteriol. Rev.20, 243-258. |
| [7] | Chen, L., Wang, R. S. & Zhang, X. S. [2009] Bimolecular Networks: Methods and Applications in Systems Biology (John Wiley & Sons, NY). |
| [8] | Chen, Z., Bai, X., Liang, M.et al. [2020] “ A branch point on differentiation trajectory is the bifurcating event revealed by dynamical network biomarker analysis of single-cell data,” IEEE ACM T. Comput. Bi.17, 366-375. |
| [9] | Chou, T. C. [2006] “ Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies,” Pharmacol. Rev.58, 621-681. |
| [10] | Chou, T. C. [2008] “ Preclinical versus clinical drug combination studies,” Leukemia Lymphoma49, 2059-2080. |
| [11] | Chou, T. C. [2010] “ Drug combination studies and their synergy quantification using the Chou-Talalay method,” Cancer Res.70, 440-446. |
| [12] | Cursons, J., Pillman, K. A., Scheer, K. G.et al. [2018] “ Combinatorial targeting by MicroRNAs co-ordinates post-transcriptional control of EMT,” Cell Syst.7, 77-91. |
| [13] | Fitzgerald, J. B., Schoeberl, B., Nielsen, U. B. & Sorger, P. K. [2006] “ Systems biology and combination therapy in the quest for clinical efficacy,” Nat. Chem. Biol.2, 458-466. |
| [14] | Greco, W. R. [1995] “ The search for synergy: A critical review from a response surface perspective,” Pharmacol. Rev.47, 331-385. |
| [15] | Guantes, R. & Poyatos, J. F. [2008] “ Multistable decision switches for flexible control of epigenetic differentiatioin,” PLoS Comput. Biol.4, e1000235. |
| [16] | Halbleib, J. M. & Nelson, W. J. [2006] “ Cadherins in development: Cell adhesion, sorting, and tissue morphogenesis,” Genes Dev.20, 3199-3214. |
| [17] | Huber, M. A., Kraut, N. & Beug, H. [2005] “ Molecular requirements for epithelial-mesenchymal transition during tumor progression,” Curr. Opin. Cell Biol.17, 548-558. |
| [18] | Jin, S., Wu, F. X. & Zou, X. [2017] “ Domain control of nonlinear networked system and applications to complex disease networks,” Discr. Contin. Dyn.-B22, 2169-2206. · Zbl 1359.93050 |
| [19] | Kuznetsov, Y. A. [1998] Elements of Applied Bifurcation Theory (Springer, NY). · Zbl 0914.58025 |
| [20] | Lamouille, S., Xu, J. & Derynck, R. [2014] “ Molecular mechanisms of epithelial-mesenchymal transition,” Nat. Rev. Mol. Cell Biol.15, 178-196. |
| [21] | Li, J., Zhang, B., Cui, J., Liang, Z. & Liu, K. [2019] “ miR-203 inhibits the invasion and EMT of gastric cancer cells by directly targeting Annexin A4,” Oncol. Res.27, 789-799. |
| [22] | Liu, Y., Li, S., Liu, Z. & Wang, R. [2016] “ Bifurcation-based approach reveals synergism and optimal combinatorial perturbation,” J. Biol. Phys.42, 399-414. |
| [23] | Loewe, S. [1953] “ The problem of synergism and antagonism of combined drugs,” Arzneimittel Forschung3, 285-290. |
| [24] | Louzoun, Y., Xue, C., Lesinski, G. B. & Friedman, A. [2014] “ A mathematical model for pancreatic cancer growth and treatments,” J. Theor. Biol.351, 74-82. · Zbl 1412.92154 |
| [25] | Luo, M., Jiao, J. & Wang, R. [2019a] “ Impulsive control of a nonlinear dynamical network and its application to biological networks,” J. Biol. Phys.45, 31-44. |
| [26] | Luo, M., Jiao, J. & Wang, R. [2019b] “ Screening drug target combinations in disease-related molecular networks,” BMC Bioinf.20, 129-138. |
| [27] | Mellman, I. & Misteli, T. [2003] “ Computational cell biology,” Cell Biol.161, 463-464. |
| [28] | Meyer, C. T., Wooten, D. J., Paudel, B.et al. [2019] “ Quantifying drug combination cynergy along potency and efficacy axes,” Cell Syst.8, 97-108. |
| [29] | Moreno-Bueno, G., Cubillo, E., Sarrió, D., Peinado, H., Rodríguez-Pinilla, S. M., Villa, S., Bolós, V.et al. [2006] “ Genetic profiling of epithelial cells expressing E-cadherin repressors reveals a distinct role for Snail, Slug, and E47 factors in epithelial-mesenchymal transition,” Cancer Res.66, 9543-9556. |
| [30] | Nieto, M. A. [2013] “ Epithelial plasticity: A common theme in embryonic and cancer cells,” Science342, 1234850. |
| [31] | Silveira, D. A., Gupta, S. & Mombach, J. C. M. [2018] “ Systems biology approach suggests new miRNAs as phenotypic stability factors in the epithelial-mesenchymal transition,” J. R. Soc. Interf.17, 20200693. |
| [32] | Singh, T., Prasad, R. & Katiyar, S. K. [2016] “ Therapeutic intervention of silymarin on the migration of non-small cell lung cancer cells is associated with the axis of multiple molecular targets including class HDACs, ZEB1 expression, and restoration of miR-203 and E-cadherin expression,” A. J. Cancer Res.6, 1287-1301. |
| [33] | Tian, X. J., Zhang, H. & Xing, J. [2013] “ Coupled reversible and irreversible bistable switches underlying TGF \(\beta \)-induced epithelial to mesenchymal transition,” Biophys. J.105, 1079-1089. |
| [34] | Tomita, K., Van Bokhoven, A., van Leenders, G. J., Ruijter, E. T., Jansen, C. F., Bussemakers, M. J. & Schalken, J. A. [2000] “ Cadherin switching in human prostate cancer progression,” Cancer Res.60, 3650-3654. |
| [35] | Wang, G. [2010] “ Singularity analysis of the AKT signaling pathway reveals connections between cancer and metabolic diseases,” Phys. Biol.7, 046015. |
| [36] | Wang, R., Liu, K., Chen, L. & Aihara, K. [2011] “ Neural fate decisions mediated by trans-activation and cisinhibition in notch signaling,” Bioinformatics27, 3158-3165. |
| [37] | Wang, Y., Xu, K. J., Song, J. & Zhao, X. [2012] “ Exploring drug combinations in genetic interaction network,” BMC Bioinf.13, 1-7. |
| [38] | Watanabe, K., Panchy, N., Noguchi, S., Suzuki, H. & Hong, T. [2019] “ Combinatorial perturbation analysis reveals divergent regulations of mesenchymal genes during epithelial-to-mesenchymal transition,” NPJ Syst. Biol. Appl.5, 1-15. |
| [39] | Wu, Z., Zhao, X. M. & Chen, L. [2010] “ A systems biology approach to identify effective cocktail drugs,” BMC Syst. Biol.4, 1-14. |
| [40] | Xiong, W. & Ferrell, J. E. [2013] “ A positive-feedback-based bistable ‘memory module’ that governs a cell fate decision,” Nature426, 460-465. |
| [41] | Zhang, Y., Smolen, P., Baxter, D. A. & Byrne, J. H. [2014] “ Computational analyses of synergism in small molecular network motifs,” PLos Comput. Biol.10, e1003524. |
| [42] | Zhao, G., Dharmadhikari, G., Maedler, K. & Michael, M. [2014] “ Possible role of interleukin-1 in type 2 diabetes onset and implications for anti-inflammatory therapy strategies,” PLoS Comput. Biol.10, e1003798. |
| [43] | Zheng, X., Carstens, J., Kim, J.et al. [2015] “ Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer,” Nature527, 525-530. |
This reference list is based on information provided by the publisher or from digital mathematics libraries. Its items are heuristically matched to zbMATH identifiers and may contain data conversion errors. In some cases that data have been complemented/enhanced by data from zbMATH Open. This attempts to reflect the references listed in the original paper as accurately as possible without claiming completeness or a perfect matching.
